November 2022 - Page 16 of 23

ThursdayNov 10, 2022 1:27 pm

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Progress on Clinical Path for CYB004

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(R), today announced progress on its CYB004-E Phase 1 trial evaluating N,N-dimethyltryptamine (“DMT”). According to the update, dosing has been completed for four out of five participant cohorts, and The Safety Review Committee has confirmed no clinically significant safety or tolerability issues. The trial was acquired from Entheon Biomedical Corp. in July 2022. “The acquisition of the Phase 1 DMT study was done with an eye toward informing and accelerating the clinical path forward for CYB004, and we are very pleased with the progress so far,”…

ThursdayNov 10, 2022 12:04 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at ‘Exploring the Neuroprotective Qualities of Rare Cannabinoids’ Webinar Event

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today announced that its CEO Eric A. Adams and SVP of Preclinical Research and Development Eric Hsu will present at Tribe Public’s upcoming webinar presentation and Q&A event. Titled “Exploring the Neuroprotective Qualities of Rare Cannabinoids,” the event is scheduled to begin at 8:30 a.m. Pacific Time on Nov. 17, 2022. Interested parties should visit https://ibn.fm/5WHrj to register for and join the complimentary, Zoom webinar-based event. Once registered, participants may begin forwarding their questions for InMed’s management to Tribe Public at…

ThursdayNov 10, 2022 11:35 am

QualityStocksNewsBreaks – Tingo Inc. (TMNA) Announces Launch of Operations in Ghana, Entry into Landmark Trade Deal with the Kingdom of Ashanti

Tingo (OTC: TMNA) today announced that Tingo Mobile PLC (“Tingo Mobile”) has opened a head office in Accra, Ghana, and has launched nationwide operations. According to the update, Tingo Mobile’s business in Ghana is held through a wholly owned subsidiary, Tingo Mobile Ghana Ltd (“Tingo Ghana”). To coincide with the launch, Tingo Ghana has agreed on a landmark trade deal with the Kingdom of Ashanti, through the Ashanti Kingdom Investment Trust. Under the terms, the Ashanti Kingdom Investment Trust has committed to enroll a minimum of 2 million new members with Tingo within 120 days of signing and has agreed…

ThursdayNov 10, 2022 11:15 am

Specialized Market Lender REZYFi, Inc. Believes They Have Real Opportunity Amid Challenges Faced by Traditional Lenders

While economies worldwide are struggling to control spiking inflation rates, REZYFi, a mortgage lender servicing non-traditional as well as other loans, sees unique financial opportunities Through the use of proprietary automated machine learning and associated technologies, together with preparations to launch a high-margin cannabis division later this year to serve an industry in need of loan origination options, REZYFi is working to grow its operation RZFI is licensed in more than 30 U.S. states and expects to expand its loan origination services to all remaining states in coming months Economic challenges resulting from governmental efforts to tame inflation could in…

ThursdayNov 10, 2022 11:02 am

QualityStocksNewsBreaks – FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) Announces Completion of Critical Milestones to Prepare for Rapid Growth

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) today issued a series of updates, news releases and images to share its progress as it enters the final assembly and validation phase of its on-farm, containerized green ammonia production system. Critical milestones, including the building its team and completing its initial manufacturing facility, R&D lab and new corporate headquarters are enabling the company to expedite the commercialization of its products. “At the same time that we’ve been working on our first demonstration system, we’ve been preparing our company to handle rapid growth. We knew early on that we needed to assemble a powerful team…

ThursdayNov 10, 2022 10:30 am

As World Pollutant Concerns Grow, Correlate Infrastructure Partners Inc. (CIPI) Helps Drive Optimism for Affordable and Effective ESG Solutions

Climate change and industrialized pollution emissions continue to raise warnings worldwide that the quality of human life is being compromised U.S.-based Correlate Infrastructure Partners is working to establish solutions for its clients by assessing utilities inefficiencies, advising on affordable improvements, and then helping to successfully implement changes through access to highly cost-effective financing opportunities The federal government’s recent passage of greenhouse gas reduction financing opportunities through the Inflation Reduction Act (“IRA”) has established the government as a ready partner in companies’ ESG policies The IRA has become particularly attractive to public, non-profit, and REIT entities because of changes to subsidy…

ThursdayNov 10, 2022 9:45 am

Reklaim Ltd. (TSX.V: MYID) (OTCQB: MYIDF) Offers Fully Compliant Data Solutions, CPRA Data Law Set to Take Effect on January 1, 2023

The CCPA limits data flows to brands and marketers, and CPRA amendments are set to take effect January 1, 2023 CPRA and CCPA provisions include the right to opt-out of data sharing and sale, as well as the right to data deletion Consumer data is critical to branding and advertising strategies Reklaim provides an ecosystem that equips marketers with fully compliant, consumer-verified data sets while rewarding consumers for sharing information With the aim of protecting consumers, the California Consumer Privacy Act (“CCPA”) and amendments provided by the California Privacy Rights Act (“CPRA”) are gradually transforming the advertising landscape by limiting…

ThursdayNov 10, 2022 9:00 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Maintains Strong Cash Position as It Continues Drug Development Program Pursuing Treatment for GBM

CNS Pharmaceuticals is focused on advancing its clinical development for the Berubicin drug candidate in order to bring meaningful treatment to GBM patients GBM, which has a low survival rate, has limited treatment options when it progresses after first-line therapy The company is looking to find a solution with Berubicin and is currently evaluating this drug candidate in a potentially pivotal global study CNS’s ongoing R&D efforts are boosted by its strong cash position; in its Q2 2022 report, the company announced it had cash of about $9.0 million and working capital of $10.5 million CNS Pharmaceuticals (NASDAQ: CNSP), an…

WednesdayNov 09, 2022 3:03 pm

QualityStocksNewsBreaks – Reklaim Ltd. (TSX.V: MYID) (OTCQB: MYIDF) Addressing Growing Demand for Fully Compliant Data Solutions

Reklaim (TSX.V: MYID) (OTCQB: MYIDF), the destination for consumers to access and reclaim their data, is focused on solutions that benefit both the consumer and advertisers by offering transparency, choice and value. “The days when companies collected consumer data and sold it to advertisers without their consent are rapidly ending as privacy regulations expand worldwide. In addition, tech companies are taking action to reduce data mining by mobile applications. At the same time, advertisers still need data to fuel marketing strategies, leading to a growing demand for fully compliant consumer data solutions. Reklaim addresses that demand with a privacy-compliant identity…

Site Search

Company Search

Month: November 2022